Drugs.com - Pharma Industry News

RSV Vaccines, Nirsevimab Tied to Reduced RSV-Linked Hospitalization

TUESDAY, May 13, 2025 -- Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated hospitalization rates among infants aged 0 to 7 months during the 2024-2025 RSV season, the first...

May 14, 2025 - 00:24
 0
RSV Vaccines, Nirsevimab Tied to Reduced RSV-Linked Hospitalization
TUESDAY, May 13, 2025 -- Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated hospitalization rates among infants aged 0 to 7 months during the 2024-2025 RSV season, the first...
Read More

Tags:

Previous Article

The ultimate power of the American consumer

Next Article

American Eagle withdraws 2025 outlook after weak first quarter

Related Posts

General Practitioners Face Barriers to Treating Patients' Sexual Problems

General Practitioners Face Barriers to Treating Patient...

May 13, 2025  0

Emergency Department Visits for Asthma Increased During 2023 Wildfires

Emergency Department Visits for Asthma Increased During...

May 5, 2025  0

Asthma Attacks Increase for Some Women Taking Progestogen-Only Pill

Asthma Attacks Increase for Some Women Taking Progestog...

May 9, 2025  0